Action INBP INTEGRATED BIOPHARMA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Integrated BioPharma, Inc.

Actions

INBP

US45811V1052

Marché Fermé - OTC Markets
Autres places de cotation
 20:39:01 15/07/2024 		Varia. 5j. Varia. 1 janv.
0,2 USD 0,00 % Graphique intraday de Integrated BioPharma, Inc. 0,00 % -18,43 %
10/05 Integrated BioPharma, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 mars 2024 CI
12/02 Integrated BioPharma, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
INTEGRATED BIOPHARMA INC Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K/A)
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INBP
  4. Actualités Integrated BioPharma, Inc.
  5. Autres langues